Skip To Main Content
Jackqueline Ardo on Muck Rack

Jackqueline Ardo

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jackqueline

Contact Jackqueline, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety and immunogenicity of a BPL-inactivated, whole-virus, universal influenza vaccine: a randomized, double-blinded, double-dummy, placebo-controlled, phase 1 clinical trial

|
By Luca T. Giurgea, Alison Han, Lindsay Czajkowski, Holly Ann Baus, Rani Athota, Robert Daniels, Viviane Callier Verified, Sally Hunsberger, Mattia Bonsignori, John H. Iii, John Powers III, John Kash, Jeffery K. Taubenberger, Matthew J. Memoli, Gregory Mak, Matthias Lingemann, Ian Bellayr, Adriana Cervantes-Medina, Monica Gouzoulis, Kimberly Adao, Jackqueline Ardo, Jaekeun Park
| Nature Verified
Abstract Influenza inflicts substantial burden of disease, but current vaccines have limited breadth of protection against strains and subtypes not in the vaccine. BPL-1357, a whole-virus, inactivated vaccine containing four wild-type, low-pathogenicity avian influenza viruses has demonstrated remarkable protection in animal models against a wide range of influenza viruses.
Open in Who Shared Issue with article?
See all 1 articles